We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
Cap. Flow
+$224M
Cap. Flow %
3.55%
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$37.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$29.3M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
HD icon
Home Depot
HD
+$22.7M
5
CSCO icon
Cisco
CSCO
+$21.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$23.6M
2
TJX icon
TJX Companies
TJX
+$19.3M
3
FDX icon
FedEx
FDX
+$16.4M
4
INTU icon
Intuit
INTU
+$14.7M
5
GLW icon
Corning
GLW
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.19%
3 Financials 12.85%
4 Consumer Discretionary 10.2%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNY icon
751
Sanofi
SNY
$104B
$1K ﹤0.01%
+26
New +$1.02K
TEF
752
DELISTED
Telefonica
TEF
$1K ﹤0.01%
+186
New +$1.42K
TEL icon
753
TE Connectivity
TEL
$58.8B
$1K ﹤0.01%
+14
New +$1.34K
EV
754
DELISTED
Eaton Vance Corp.
EV
$1K ﹤0.01%
+22
New +$1.21K
AGEN
755
Agenus
AGEN
$249M
– –
-18,852
Closed -$1.74M
AMG icon
756
Affiliated Managers Group
AMG
$9.46B
– –
-1,080
Closed -$205K
AOS icon
757
A.O. Smith
AOS
$8.38B
– –
-6,881
Closed -$438K
AVY icon
758
Avery Dennison
AVY
$12.3B
– –
-4,245
Closed -$451K
AXS icon
759
AXIS Capital
AXS
$8.59B
– –
-7,509
Closed -$432K
AYI icon
760
Acuity Brands
AYI
$9.88B
– –
-3,098
Closed -$431K
BHF icon
761
Brighthouse Financial
BHF
$3.63B
– –
-6,165
Closed -$317K
BR icon
762
Broadridge
BR
$17.2B
– –
-5,000
Closed -$548K
BRO icon
763
Brown & Brown
BRO
$22.9B
– –
-20,000
Closed -$509K
CBOE icon
764
Cboe Global Markets
CBOE
$29.8B
– –
-6,094
Closed -$695K
CCJ icon
765
Cameco
CCJ
$38.3B
– –
-11,247
Closed -$102K
CDNS icon
766
Cadence Design Systems
CDNS
$90B
– –
-8,839
Closed -$325K
CDP icon
767
COPT Defense Properties
CDP
$4.31B
– –
-19,000
Closed -$491K
CHRS icon
768
Coherus Oncology
CHRS
$217M
– –
-85,000
Closed -$939K
COO icon
769
Cooper Companies
COO
$13.7B
– –
-74,416
Closed -$4.26M
CPT icon
770
Camden Property Trust
CPT
$11.3B
– –
-13,822
Closed -$1.16M
CUZ icon
771
Cousins Properties
CUZ
$5.29B
– –
-14,500
Closed -$503K
DHC
772
Diversified Healthcare Trust
DHC
$2.26B
– –
-24,000
Closed -$376K
DVAX
773
DELISTED
Dynavax Technologies
DVAX
– –
-69,000
Closed -$1.37M
EG icon
774
Everest Group
EG
$15.2B
– –
-1,090
Closed -$280K
EXK
775
Endeavour Silver
EXK
$2.32B
– –
-24,000
Closed -$58K
29 30
31
32 33

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2018 Portfolio in Review

As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.

  • Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
  • Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
  • Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
  • Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
  • Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
  • Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
  • Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.